Avantor, Inc. (NYSE:AVTR) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC lowered its stake in shares of Avantor, Inc. (NYSE:AVTR) by 2.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,257,000 shares of the company’s stock after selling 417,225 shares during the period. Janus Henderson Group PLC owned about 2.10% of Avantor worth $364,550,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of AVTR. Norges Bank purchased a new stake in Avantor during the 4th quarter worth approximately $156,455,000. CCLA Investment Management boosted its stake in shares of Avantor by 147,220.3% in the first quarter. CCLA Investment Management now owns 4,720,144 shares of the company’s stock worth $120,828,000 after acquiring an additional 4,716,940 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Avantor in the fourth quarter worth approximately $93,433,000. Avidity Partners Management LP purchased a new stake in shares of Avantor during the fourth quarter worth approximately $48,442,000. Finally, Magnetar Financial LLC acquired a new position in Avantor in the 1st quarter valued at $35,154,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Robert W. Baird lifted their target price on shares of Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a research note on Monday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $31.00 price objective on shares of Avantor in a research note on Monday. Evercore ISI decreased their target price on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Barclays upped their price target on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday. Finally, Morgan Stanley lifted their price objective on Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday. Five analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $27.00.

Insiders Place Their Bets

In related news, insider Christophe Couturier 10,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is owned by insiders.

Avantor Trading Up 5.3 %

AVTR stock traded up $1.40 during mid-day trading on Tuesday, hitting $27.65. 11,482,278 shares of the company were exchanged, compared to its average volume of 6,993,731. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $27.66. The firm has a market capitalization of $18.78 billion, a P/E ratio of 67.29, a PEG ratio of 2.63 and a beta of 1.32. The business has a fifty day simple moving average of $22.42 and a 200-day simple moving average of $23.67. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.52%. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $0.29 EPS. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. On average, equities research analysts predict that Avantor, Inc. will post 1 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.